Market Tracker

04/28 5:16pm ET

Clovis Oncology Inc (NASDAQ:CLVS)

57.89
Delayed Data
As of Apr 28
 -0.32 / -0.55%
Today’s Change
11.57
Today|||52-Week Range
74.94
+30.32%
Year-to-Date

Today’s Trading

Previous close58.21
Today’s open58.33
Day’s range56.76 - 59.24
Volume1,237,181
Average volume (3 months)2,233,197
Market cap$2.6B
Dividend yield--
Data as of 4:00pm ET, 04/28/2017

Growth & Valuation

Earnings growth (last year)+7.35%
Earnings growth (this year)+43.49%
Earnings growth (next 5 years)+29.49%
Revenue growth (last year)--
P/E ratioNM
Price/Sales21,912.70
Price/Book--

Competitors

 Today’s
change
Today’s
% change
AXONAxovant Sciences Ltd-0.11-0.45%
SAGESAGE Therapeutics In...-0.72-1.00%
ENDPEndo International P...+0.09+0.80%
----
Data as of 4:00pm ET, 04/28/2017

Financials

Next reporting dateMay 4, 2017
EPS forecast (this quarter)-$1.44
Annual revenue (last year)$78.0K
Annual profit (last year)-$349.1M
Net profit margin-447,611.54%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Patrick J. Mahaffy
SVP-Finance, Chief Financial &
Accounting Officer
Daniel W. Muehl
Corporate headquarters
Boulder, Colorado

Forecasts